Skip to main content

Table 2 Mean of three distances (mm) measured over the swelling using Laskin method (mean ± SEM)

From: Efficacy of serratiopeptidase after impacted third molar surgery: a randomized controlled clinical trial

Groups Preoperative (Day 0) Postoperative (Day 4) (Day 5)
DHC    
 Test 108.41 ± 8.6 111.49 ± 8.1*** 109.29 ± 8.2***
 Control 109.98 ± 9.7 115.39 ± 9.9*** 114.01 ± 9.8***
 Effect size (d) 0.67 1.07  
DHS    
 Test 147.14 ± 10.2 150.76 ± 9.1** 148.1 ± 9.1***
 Control 146.01 ± 13.6 151.12 ± 14.2** 150.1 ± 14.1***
 Effect size (d) 0.45 0.97  
DV    
 Test 104.26 ± 13.4 106.17 ± 13.7***104.73 ± 13.5***  
 Control 103.98 ± 9.9 107.42 ± 9.7*** 106.19 ± 9.7***
 Effect size (d) 0.69 0.98  
  1. Significance of treatment group in comparison with placebo on respective days
  2. **p < 0.01; ***p < 0.001